RecruitingNot applicableNCT07328737

One vs Three HIPEC Cycles After CRS for Pseudomyxoma Peritonei

Studying Pseudomyxoma peritonei

Last synced from ClinicalTrials.gov May 7, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Beijing Tsinghua Chang Gung Hospital
Intervention: One HIPEC session(procedure)
Enrollment: 132 enrolled
Eligibility: 18-70 years · All sexes
Timeline: 2025 – 2030

Study locations (1)

Tsinghua University affiliated Beijing Tsinghua Changgung Hospital, Beijing, Changping, China

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07328737 on ClinicalTrials.gov

Other trials for Pseudomyxoma peritonei

Additional recruiting or active studies for the same condition.

RECRUITINGEARLY PHASE1NCT07341360
Pseudovax - A Cancer Vaccine for Patients With Pseudomyxoma Peritonei
Oslo University Hospital
RECRUITINGNCT02073500
Peritoneal Surface Malignancies - Characterization, Models and Treatment Strategies
Oslo University Hospital

See all trials for Pseudomyxoma peritonei →

← Back to all trials